Meeting
Abstract Number: 676
SHM Converge 2024
Case Presentation: In September 2021, a 53-year-old male with a BMI of 30.91 and no history of alcohol use was diagnosed with advanced prostate cancer, indicated by a PSA level of 111. A transrectal ultrasound-guided prostate biopsy revealed Gleason score 4+5 prostate adenocarcinoma. In February 2022, the patient initiated treatment with Androgen Deprivation Therapy (ADT) […]